In parallel, macrophages in tumor-affected lymph nodes showed a shift from MHC class I/II<sup>hi</sup> to MHC I/II<sup>lo</sup> subsets and reduced co-expression of MHC molecules with CD80 and CD86, indicating impaired antigen-presenting features. Here, CD86 is linked to neoplasm.